Chymotrypsin
Based on 3 publication(s) in Google Scholar
Chymotrypsin (EC 3.4.21.1; Chymotrypsin A) is an orally effective inhibitor targeting molecules such as TLR4, NF-κB, MMP-1, TNF-α, IL-1β, and IL-6. Chymotrypsin downregulates the TLR4/NF-κB signaling pathway, inhibiting the release of inflammatory factors, reducing cell infiltration and tissue damage. It also reduces the expression of tumor cell adhesion molecules (such as CD44 and CD54) and can be specifically detected by fluorescent probes (such as NBD-3). Chymotrypsin has anti-inflammatory, hepatoprotective, joint damage-reducing, liver protection against lipotoxicity, and anti-tumor metastasis functions. It can be used in research on diseases such as rheumatoid arthritis, non-alcoholic fatty liver disease, and melanoma metastasis. Chymotrypsin can be used in studies of inflammation, edema, and expectoration.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 9004-07-3
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Chymotrypsin
More-
WB
Activité biologique
Description
IC50 & Target
|
MMP-1 |
TLR4 |
In Vitro
Chymotrypsin mixed with Trypsin (HY-129047) and Papain (HY-P1645) was used as a treatment group in in vitro studies (with a Chymotrypsin content of 0.2 mg/0.1 mL), causing a decrease in CD44 expression in SMMU-2, SK-MEL 28, B16F10 melanoma cells, MOLT 4/8 leukemia cells, and breast cancer cells[3].
Chymotrypsin selectively reduces the density of CD4, CD44, and CD80 molecules in peripheral lymphocytes[3].
Chymotrypsin can be detected by the probe NBD-3 (2 mM), with a detection concentration of 0-6 g/mL and a reaction time of 20 minutes, producing red fluorescence at 634 nm under an excitation wavelength of 550 nm, with a detection limit of 15. ng/mL. Furthermore, its activity can be inhibited by the inhibitor phenylmethylsulfonyl fluoride (PMSF)[4];
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SMMU-2 melanoma cells, SK-MEL 28 melanoma cells, MOLT 4/8 leukemia cells, mammary carcinoma cells, peripheral lymphocytes, B16F10 mouse melanoma cells
-
Concentration:Mixture containing chymotrypsin (0.2 mg/0.1 ml), trypsin (0.2 mg/0.1 ml), and papain (0.5 mg/0.1 ml)
-
Incubation Time:
-
Result:Exposure to the mixture of chymotrypsin, trypsin, and papain reduced the expression of CD44 in SMMU-2 melanoma cells, SK-MEL 28 melanoma cells, MOLT 4/8 leukemia cells, mammary carcinoma cells, and B16F10 mouse melanoma cells.
Additionally, it selectively decreased the density of CD4, CD44, and CD80 molecules on peripheral lymphocytes in vitro.
In Vivo
Chymotrypsin (in combination with trypsin, 3 EAU/kg; oral gavage; once daily; 5 weeks) protectes the liver from damage in an olanzapine-induced non-alcoholic steatohepatitis (NASH) model in young adult male albino rats, significantly reducing olanzapine-induced elevated ALT, AST, ALP, total cholesterol, and LDL-C, reducing steatosis scores and hepatocyte necrosis, increasing Ki67 expression, and not affecting the memory function of the rats[2].
Chymotrypsin (mixed with trypsin and papain, 0.2 mg/0.1 mL mixture; rectal administration; twice daily; 100 days) inhibits primary tumor growth, reduces tumor recurrence and metastasis (including lung and distant metastasis), prolongs mouse survival time, and reduced the expression of CD44 and CD54 molecules in tumor cells in a B16 melanoma metastasis model in female inbred C57Bl6 mice[3].
The NBD-3 probe detects endogenous chymotrypsin in mouse liver[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley rats adjuvant-induced arthritis (AIA) model[1]
-
Dosage:Low dose 0.53 mg/kg, high dose 1.06 mg/kg
-
Administration:
-
Result:Attenuated joint damage of AIA rats, suppressed paw swelling and arthritic scores, and reduced synovial hyperplasia, inflammatory cell infiltration, pannus formation, and bone destruction.
The overproduction of MMP-1, TNF-α, IL-1β, and IL-6 in serum was remarkably attenuated, and the protein levels of TLR4 and NF-κB in synovial tissue as well as the mRNA expression of TLR4, NF-κB, TNF-α, IL-1β, and IL-6 in synovial tissue were substantially declined.
-
Animal Model:Female inbred C57Bl6 mice (average body weight 18-20 g) syngeneic B16 melanoma metastatic model[3]
-
Dosage:0.2 mg chymotrypsin combined with 0.2 mg trypsin and 0.5 mg papain per 0.1 mL
-
Administration:
-
Result:Inhibited the growth of primary tumors, with the mean tumor size in the treated group (E1) being statistically significantly smaller (47.2 mm3) than that in all control groups. Reduced the number of tumor recurrences (6% in E1 and 2% in E2 vs 30% in C1 and C2) and considerably curtailed metastasis (46% pulmonary metastases in E1 and 68% in E2 vs 95% in C1 and 90% in C2). Extended the survival time of the mice, with the mean survival time of 72.06 days in E1 and 54.92 days in E2, compared to 27.25 days in C1 and 28.65 days in C2, and 46% of mice in E1 and 30% in E2 survived until the end of the 100-day study.
Correlated with a decreased expression of CD44 and CD54 molecules in ascitic tumor cells.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
EC Number
3.4.21.1
Enzyme Activity
≥1000 U/mg soild
Unit Definition
One unit is defined as the amount of enzyme that causes a decrease in the absorbance at 237 nm of 0.001 in per minute at 25°C, pH 7.0.
Technical Parameters
-
Biological Source
Pancreas
Chemical Information
-
CAS No. 9004-07-3
-
Appearance Solid
-
Color White to off-white
-
SMILES
[Chymotrypsin]
-
Synonyms
EC 3.4.21.1; Chymotrypsin A
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Nat Protoc
Design, performance, processing, and validation of a pooled CRISPR perturbation screen for bacterial toxins. [Abstract]2025 May;20(5):1158-1195. PMID: 39487259
Chymotrypsin purchased from MedChemExpress. Usage Cited in: Nat Protoc. 2025 May;20(5):1158-1195. [Abstract]
Vibrio cholerae cytolysin (VCC) was produced as an inactive pro-toxin (80 kDa), and the mature toxin (65 kDa) was generated through proteolysis by Chymotrypsin (incubated with VCC at 1000:1 molar ratio; room temperature; 2 h). A representative gel for in-house produced His-tagged pro-VCC and its proteolysis activation was shown. Both the toxin purity (the major band was toxin, with few degradation bands) and activation efficiency were satisfactory.
-
J Med Chem
Peptidomimetic Analogues Act as Effective Inhibitors against SARS-CoV-2 by Blocking the Function of Cathepsin L. [Abstract]2024 Oct 10;67(19):17124-17143. PMID: 39292661 -
PLoS Pathog
Serine protease-driven entry and S2 ' cleavage flexibility of feline coronavirus during feline enterocyte infections. [Abstract]2026 Jan 8;22(1):e1013854. PMID: 41505483
Solvant et solubilité
In Vitro:
H2O : ≥ 33.33 mg/mL
* "≥" means soluble, but saturation unknown.
Protocole
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Collagen-Induced Arthritis
Collagen-induced arthritis (CIA) is an autoimmune murine model of rheumatoid arthritis in which immunization with type II collagen (CII) emulsified in an adjuvant induces a T cell- and autoantibody-driven inflammatory arthritis characterized by synovial hyperplasia, immune cell infiltration, and joint destruction. The model typically relies on genetically susceptible mouse strains (e. g. , DBA/1) and reproduces key features of human rheumatoid arthritis, including anti-collagen immune responses and progressive joint inflammation. Disease onset generally occurs within ~3-4 weeks after immunization, depending on antigen/adjuvant combinations and protocol variation. The immunopathology is driven by adaptive immune activation against CII, leading to systemic and local joint inflammation mediated by pro-inflammatory cytokines and effector immune cells, making CIA a standard preclinical platform for evaluating immunomodulatory and anti-arthritic interventions.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Orthotopic Cell-Line Xenograft
Orthotopic cell-line xenograft models involve implantation of human cancer cell lines into the anatomically corresponding organ of immunodeficient mice to reproduce tumor growth within a native microenvironment, enabling more clinically relevant tumor behavior compared with subcutaneous models. These models are widely used because orthotopic placement better recapitulates tumor progression, including invasion and metastatic spread, which are often underrepresented in heterotopic implantation systems. Compared with conventional xenografts, orthotopic implantation is described as more technically complex but provides improved simulation of tumor-microenvironment interactions and metastatic behavior, making it particularly valuable for translational oncology research. Surgical orthotopic implantation approaches have been emphasized as enabling faithful reproduction of clinical cancer features, including metastasis and disease progression patterns that align with the tumor’s organ of origi
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Pureté et documentation
-
Fiche technique (279 KB)
-
SDS (702 KB)
- English - EN (702 KB)
- Français - FR (702 KB)
- Deutsch - DE (702 KB)
- Norwegian - NO (702 KB)
- Español - ES (702 KB)
- Swedish - SV (702 KB)
- Italian - IT (702 KB)
- Korean - KR (702 KB)
- Portuguese - PT (702 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Li J, et al. Chymotrypsin attenuates adjuvant-induced arthritis by downregulating TLR4, NF-κB, MMP-1, TNF-α, IL-1β, and IL-6 expression in Sprague-Dawley rats. Immunopharmacol Immunotoxicol. 2022 Dec;44(6):959-969. [Content Brief]
[2]. Mahmoud GS, et al. Hepatoprotective effect of trypsin/chymotrypsin against olanzapine-induced non-alcoholic steatohepatitis in rats. Can J Physiol Pharmacol. 2021 Oct;99(10):1088-1096. [Content Brief]
[3]. Wald M, et al. Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S16-22. [Content Brief]
[4]. Jancsó Z, et al. Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice. Gastroenterology. 2018 Oct;155(4):1017-1021. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)